Table 2 Gemcitabine administration

From: Domiciliary chemotherapy with gemcitabine is safe and acceptable to advanced non-small-cell lung cancer patients: results of a feasibility study

    

Number of infusions

Cycle

No. of patients

No. of planned infusions

Number omitted

Home

Hospital

1

24

72

4

—

68

2

21

63

5

53 (91%)

5 (9%)

3

15

45

5

35 (88%)

5 (12.5%)

4

12

36

2

31 (91%)

3 (9%)

5

6

18

2

16 (100%)

0

6

5

15

2

12 (92%)

1 (8%)

Back to article page